Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients

被引:3
作者
Chen, Min [1 ,2 ]
Chen, Ting [1 ]
机构
[1] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu, Peoples R China
[2] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu 215500, Peoples R China
关键词
early onset colorectal cancer; conditional survival; nomogram; overall survival; cancer-specific survival;
D O I
10.1093/jjco/hyac169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Conditional survival accounts for the time already survived after surgery and provides additional survival information. The aim was to assess conditional survival in stages I-III early onset colorectal cancer patients and to create nomograms predicting the conditional overall survival and cancer-specific survival after surgery. Methods A total of 7058 patients who underwent surgical resection of early onset colorectal cancer were identified from surveillance, epidemiology and end results database. The formula used for conditional survival calculation was conditional survival((x|y)) = S(x + y)/S-(x), where S-(x) represents the survival at x years. Conditional survival nomograms were then developed to predict the 5-year conditional overall survival and cancer-specific survival. Results The 5-year overall survival and cancer-specific survival after surgery increases gradually with additional survival time. Race, tumour site, grade, histology, T stage, N stage, lymph node ratio, preoperative carcinoma embryonic antigen level and perineural invasion status were independent predictors of cancer-specific survival, while age and sex were another two independent risk factors for overall survival. The nomograms based on these factors were successfully developed to predict 5-year overall survival and cancer-specific survival given 1-4 years already survived. Conclusion The probability of achieving postoperative 5-year overall survival and cancer-specific survival for early onset colorectal cancer increases gradually with additional time survived. The developed nomograms are fairly valuable and informative in facilitating clinical treatment and follow-up schemes. No previous studies have attempted to analyse the conditional survival for early onset colorectal cancer patients. We successfully developed nomograms to predict conditional survival with considerable prognostic accuracy for these patients.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 20 条
[1]   Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months A Single Institutional Study [J].
Ali, Nadia D. ;
Donohue, Kristen ;
Zandieh, Shadi ;
Chen, Chunxia ;
Moore, Dirk ;
Poplin, Elizabeth ;
Shah, Mihir M. ;
Nosher, John ;
Gui, Bin ;
Jabbour, Salma K. ;
Spencer, Kristen ;
Carpizo, Darren R. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (06) :512-518
[2]   Perineural invasion is associated with poor prognosis of colorectal cancer: a retrospective cohort study [J].
Cao, Yinghao ;
Deng, Shenghe ;
Yan, Lizhao ;
Gu, Junnan ;
Li, Jiang ;
Wu, Ke ;
Cai, Kailin .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (06) :1067-1075
[3]   Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study [J].
Fernandez, Laura M. ;
Sao Juliao, Guilherme P. ;
Figueiredo, Nuno L. ;
Beets, Geerard L. ;
van der Valk, Maxime J. M. ;
Bahadoer, Renu R. ;
Hilling, Denise E. ;
Kranenbarg, Elma Meershoek-Klein ;
Roodvoets, Annet G. H. ;
Renehan, Andrew G. ;
van de Velde, Cornelis J. H. ;
Habr-Gama, Angelita ;
Perez, Rodrigo O. .
LANCET ONCOLOGY, 2021, 22 (01) :43-50
[4]   Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin [J].
Fontana, Elisa ;
Meyers, Jeff ;
Sobrero, Alberto ;
Iveson, Timothy ;
Shields, Anthony F. ;
Taieb, Julien ;
Yoshino, Takayuki ;
Souglakos, Ioannis ;
Smyth, Elizabeth C. ;
Lordick, Florian ;
Moehler, Markus ;
Giraut, Anne ;
Harkin, Andrea ;
Labianca, Roberto ;
Meyerhardt, Jeffrey ;
Andre, Thierry ;
Boukovinas, Ioannis ;
Lonardi, Sara ;
Saunders, Mark ;
Vernerey, Dewi ;
Oki, Eiji ;
Georgoulias, Vassilis ;
Ben-Aharon, Irit ;
Shi, Qian .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) :4009-+
[5]   Conditional survival estimates for cancer patients [J].
Haydu, Lauren E. ;
Scolyer, Richard A. ;
Thompson, John F. .
ONCOTARGET, 2017, 8 (49) :84639-84640
[6]   Statistical Methods for Conditional Survival Analysis [J].
Jung, Sin-Ho ;
Lee, Ho Yun ;
Chow, Shein-Chung .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (05) :927-938
[7]   Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When [J].
Karagkounis, Georgios ;
Liska, David ;
Kalady, Matthew F. .
DISEASES OF THE COLON & RECTUM, 2019, 62 (01) :33-39
[8]   Personalizing prognostic prediction in early-onset Colorectal Cancer [J].
Liu, Jian ;
Liu, Zhengru ;
Li, Jiao ;
Tian, Shan ;
Dong, Weiguo .
JOURNAL OF CANCER, 2020, 11 (22) :6727-6736
[9]   Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer [J].
Macedo, Filipa ;
Sequeira, Hugo ;
Ladeira, Katia ;
Bonito, Nuno ;
Viana, Charlene ;
Martins, Sandra .
FUTURE ONCOLOGY, 2021, 17 (12) :1519-1532
[10]   Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes [J].
Mahar, Alyson L. ;
Compton, Carolyn ;
Halabi, Susan ;
Hess, Kenneth R. ;
Weiser, Martin R. ;
Groome, Patti A. .
JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) :969-982